An assessment of patient and pharmacist knowledge of and attitudes toward reporting adverse drug events due to formulation switching in patients with epilepsy

Garnett, 2000, Antiepileptic drug treatment: outcomes and adherence, Pharmacotherapy, 20, 191S, 10.1592/phco.20.12.191S.35250 Krämer, 2007, Current approaches to the use of generic antiepileptic drugs, Epilepsy Behav, 11, 46, 10.1016/j.yebeh.2007.03.014 Crawford, 2006, Are there potential problems with generic substitution of antiepileptic drugs? A review of issues, Seizure, 15, 165, 10.1016/j.seizure.2005.12.010 Guberman, 2000, Generic substitution for brand name antiepileptic drugs: a survey, Can J Neurol Sci, 27, 37, 10.1017/S0317167100051957 Wilner, 2004, Therapeutic equivalency of generic antiepileptic drugs: results of a survey, Epilepsy Behav, 5, 995, 10.1016/j.yebeh.2004.05.011 Haskins, 2005, Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy, Epilepsy Behav, 7, 98, 10.1016/j.yebeh.2005.04.005 McAuley, 1999, Assessing the needs of pharmacists and physicians in caring for patients with epilepsy, J Am Pharm Assoc, 39, 499 Berg, 2007, What’s the problem with generic antiepileptic drugs? A call to action, Neurology, 68, 1245, 10.1212/01.wnl.0000262876.37269.8b Carreño, 2008, Strategies to detect adverse effects of antiepileptic drugs in clinical practice, Epilepsy Behav, 13, 178, 10.1016/j.yebeh.2008.02.006